CANF
Price
$3.18
Change
+$0.07 (+2.25%)
Updated
Jun 4, 12:51 PM (EDT)
Capitalization
6.85M
Intraday BUY SELL Signals
LONA
Price
$8.79
Change
+$0.16 (+1.85%)
Updated
Jun 4, 12:58 PM (EDT)
Capitalization
84.73M
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CANF vs LONA

Header iconCANF vs LONA Comparison
Open Charts CANF vs LONABanner chart's image
CANF vs LONA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CANF vs. LONA commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANF is a Hold and LONA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (CANF: $3.11 vs. LONA: $8.77)
Brand notoriety: CANF and LONA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CANF: 3% vs. LONA: 94%
Market capitalization -- CANF: $6.85M vs. LONA: $84.73M
CANF [@Biotechnology] is valued at $6.85M. LONA’s [@Biotechnology] market capitalization is $84.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANF’s FA Score shows that 1 FA rating(s) are green whileLONA’s FA Score has 1 green FA rating(s).

  • CANF’s FA Score: 1 green, 4 red.
  • LONA’s FA Score: 1 green, 4 red.
According to our system of comparison, LONA is a better buy in the long-term than CANF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANF’s TA Score shows that 4 TA indicator(s) are bullish while LONA’s TA Score has 3 bullish TA indicator(s).

  • CANF’s TA Score: 4 bullish, 5 bearish.
  • LONA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CANF is a better buy in the short-term than LONA.

Price Growth

CANF (@Biotechnology) experienced а -7.16% price change this week, while LONA (@Biotechnology) price change was -10.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.33%. For the same industry, the average monthly price growth was +0.55%, and the average quarterly price growth was +6.31%.

Reported Earning Dates

LONA is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (-0.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LONA($84.7M) has a higher market cap than CANF($6.85M). LONA YTD gains are higher at: 15.852 vs. CANF (-22.250). CANF has higher annual earnings (EBITDA): -8.91M vs. LONA (-41.83M). LONA has more cash in the bank: 67.7M vs. CANF (995K). CANF has less debt than LONA: CANF (90K) vs LONA (691K). CANF has higher revenues than LONA: CANF (560K) vs LONA (0).
CANFLONACANF / LONA
Capitalization6.85M84.7M8%
EBITDA-8.91M-41.83M21%
Gain YTD-22.25015.852-140%
P/E RatioN/AN/A-
Revenue560K0-
Total Cash995K67.7M1%
Total Debt90K691K13%
FUNDAMENTALS RATINGS
CANF: Fundamental Ratings
CANF
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CANFLONA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 23 days ago
75%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CANF
Daily Signal:
Gain/Loss:
LONA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WASAX24.11N/A
N/A
Nomura Asset Strategy Fund Cl A
REEIX21.98N/A
N/A
RBC Emerging Markets Equity I
CNZLX13.12N/A
N/A
Commonwealth Australia/New Zealand
DEQAX15.22-0.02
-0.13%
BNY Mellon Global Equity Income - A
DGOYX48.84-0.48
-0.97%
Davis Opportunity Y

CANF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CANF has been closely correlated with APVO. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if CANF jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
N/A
APVO - CANF
94%
Closely correlated
+0.10%
GNPX - CANF
93%
Closely correlated
-2.43%
MLEC - CANF
89%
Closely correlated
+20.35%
ICU - CANF
88%
Closely correlated
-7.08%
LONA - CANF
78%
Closely correlated
-2.77%
More

LONA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LONA has been closely correlated with APVO. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if LONA jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LONA
1D Price
Change %
LONA100%
-2.77%
APVO - LONA
81%
Closely correlated
+0.10%
CANF - LONA
78%
Closely correlated
N/A
GNPX - LONA
76%
Closely correlated
-2.43%
ICU - LONA
73%
Closely correlated
-7.08%
MLEC - LONA
73%
Closely correlated
+20.35%
More